Shibutani, T., Goto, R., Miyazaki, I., Hashimoto, A., Suzuki, T., Ishida, K., . . . Ohkubo, S. (2024). Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy. Nature Portfolio.
Chicago Style (17th ed.) CitationShibutani, Toshihiro, et al. Author Correction: Modulation of Tumor Immune Microenvironment by TAS-115, a Multi-receptor Tyrosine Kinase Inhibitor, Promotes Antitumor Immunity and Contributes Anti-PD-1 Antibody Therapy. Nature Portfolio, 2024.
MLA (9th ed.) CitationShibutani, Toshihiro, et al. Author Correction: Modulation of Tumor Immune Microenvironment by TAS-115, a Multi-receptor Tyrosine Kinase Inhibitor, Promotes Antitumor Immunity and Contributes Anti-PD-1 Antibody Therapy. Nature Portfolio, 2024.